On Friday, May 5th, NEWDIGS at Tufts Medical Center co-hosted a research symposium with fellow researchers and long-time collaborators from Utrecht University and Harvard Medical School (HMS). The event, titled Uncertainty … Read More
How an RWE Value-Based Infrastructure Could Enable Payment Innovation
Tuesday, June 13, 2023 The Center for Biomedical System Design’s (CBSD) NEWDIGS at Tufts Medical Center and the Innovative Medicines Initiative’s Health Outcomes Observatory (H2O) are pleased to announce that we will … Read More
NEWDIGS Consortium Awarded Danaher Foundation Community Impact Grant
The New Drug Development Paradigms (NEWDIGS) initiative is pleased to announce that it was recently awarded a Community Impact grant from the Danaher Foundation to support its ongoing innovation efforts … Read More
Meet Marcelien Callenbach, FoCUS visiting research fellow
At NEWDIGS we welcome the opportunity to be part of rising innovation leaders’ careers, so this spring we’re excited to welcome Marcelien Callenbach, MS as a visiting scholar. While at … Read More
Precision Reimbursement Roundtable Proceedings
A framework to promote broader adoption of payment innovation As pharmaceutical companies launch novel products and payers strive to manage treatment costs and affordabili- ty, patient access can suffer. Payment … Read More
Health system innovation consortium NEWDIGS joins Tufts Medical Center
Media Contact: Jeremy Lechan508-333-4852jlechan@tuftsmedicalcenter.org Internationally esteemed “think and do” tank moved to the new Center for Biomedical System Design within Tufts MC’s Institute for Clinical Research and Health Policy Studies … Read More
NEWDIGS welcomes Takeda Pharmaceuticals as a new collaborator in the LEAPS Project
Takeda Pharmaceutical, a global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide, has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New … Read More
FoCUS Monthly Recap: April 2022
RESEARCH BRIEF How can self-insured employers prepare for the portfolio impact of high-cost gene therapies coming to market? Self-insured employers currently rely on traditional stop-loss insurance to protect against unexpected … Read More
LEAPS Monthly Recap: April 2022
NEW MEMBER NEWDIGS welcomes Takeda Pharmaceuticals as a new collaborator in the LEAPS Project Takeda Pharmaceutical, a global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people … Read More
FoCUS Monthly Recap: February 2022
JUST RELEASED Paying for Cures Toolkit updated with new pipeline modeling and financing strategies FoCUS released an updated and expanded version of its Paying for Cures Toolkit, which is designed to … Read More